NicOx withdraws naproxcinod MAA

NicOx S.A. (Euronext:COX) fell EUR 0.46 (20%) to EUR 1.82 after it withdrew an MAA in Europe for osteoarthritis (OA) candidate naproxcinod. The company said EMA's CHMP indicated that the committee would not issue a positive opinion for the application. NicOx is evaluating options for further development of the product. ...